LifeStance (LFST) Extends Rally to 5th Day on Strong Investor Confidence

We recently published 10 Stocks Crushing While Wall Street Naps. LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the top performers on Thursday.

LifeStance Health extended its winning streak to a 5th straight day on Thursday, adding another 7.93 percent to close at $5.58 apiece, on strong investor confidence supported by an impressive earnings performance.

In its updated report on Wednesday, LifeStance Health Group, Inc. (NASDAQ:LFST) said it narrowed its net loss by 84 percent to $3.8 million from $23.3 million in the same period last year. Revenues increased by 11 percent to $345.3 million from $312.3 million year-on-year on the back of a higher visit volume supported by an 11-percent net clinician growth.

Clinician base ended at 7,708 during the period, an increase of 173 from the first quarter of the year.

“I am incredibly proud of the LifeStance team for the strong results achieved in the second quarter,” said LifeStance Health Group, Inc. (NASDAQ:LFST) CEO Dave Bourdon, underscoring the double-digit organic revenue growth and 10 percent adjusted EBITDA margin.

Following the strong performance, LifeStance Health Group, Inc. (NASDAQ:LFST) reaffirmed its full-year revenue growth target of $1.4 billion to $1.44 billion, as well as adjusted EBITDA to $140 million to $150 million.

While we acknowledge the potential of LFST as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.